Respiratory Syncytial Virus (RSV) - Clinical Research Associates, Inc.

RSV Vaccine Studies

For Infants and Children Ages 6-Months to 5-Years-Old. Compensation is provided to study participants.

RSV (Respiratory Syncytial Virus) is a common seasonal virus. Infants and children are at greater risk of acquiring RSV because of their maturing immune system and lack of prior exposure. Most of the time it causes a mild illness like a cold, but for some children RSV leads to a more severe lung problem.

Unfortunately, 2-3 infants out of every 100 with RSV infections become hospitalized. In fact, each year in the United States an estimated 58,000 – 80,000 children younger than 5 are hospitalized due to RSV infection.

Compensation of $720 - $1,040 is available for study participants.

Please complete the form below if you would like to learn more from our team about participating, or give us a call at (615) 329-2222 with any questions.

Help Research an RSV Vaccine That Protects Infants and Children

Please share your name and contact information so that we can speak with you about the study, answer any questions, and plan an initial visit.

Your Name(Required)

First Last

Your Email Address(Required)

Your Phone Number(Required)

How would you describe yourself?*

Alaska Native

Asian

American Indian

Black or African American

Native Hawaiian or Other Pacific Islander

White

Hispanic or Latino or Spanish Origin

Prefer Not to Say

*Please check all that apply.

CAPTCHA

Phone

This field is for validation purposes and should be left unchanged.

Read About the Study Here

The purpose of this global study is to further evaluate the safety and effectiveness of a research RSV vaccine compared to a placebo. The study will last approximately 24 months.

Currently there are two FDA approved vaccines for RSV, both for adults 60 and older. There is no approved vaccine for infants and children.

What Does the Study Require?

RSV surveillance by parents for two RSV seasons (via phone/email etc.)
Three office visits and additional illness visits if necessary
Two or more blood draws
Two nasal administrations of research vaccine/placebo

Who Can Participate?

Enrollment is currently closed, but children ages 6 months to <22 months may be able to enroll prior to the 2025 RSV season.
Participants and parents/guardians who are able to attend all scheduled visits
Participants must generally be in good health.
We will discuss additional criteria during the informed consent process.

How to Learn More?

You may call our office at 615-329-2222 and speak with our team or fill out the brief form above and we will reach out to you.

Our team will need to speak with you to determine your interest and to see if your child qualifies.

The phone call will take about 10 minutes or less, and an appointment can be made to visit our office at 1500 Church St. There are no obligations if you inquire. There is no cost and compensation is provided to all participants and their families.